Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?
Open Access
- 27 April 2014
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 226
Abstract
Vertebral osteomyelitis (VO) may lead to disabling neurologic complications. Little evidence exists on optimal antibiotic management.Keywords
This publication has 34 references indexed in Scilit:
- Antimicrobial treatment concepts for orthopaedic device-related infectionClinical Microbiology and Infection, 2012
- Spondylodiscitis: update on diagnosis and managementJournal of Antimicrobial Chemotherapy, 2010
- A Randomized Clinical Trial to Compare Fleroxacin-Rifampicin with Flucloxacillin or Vancomycin for the Treatment of Staphylococcal InfectionClinical Infectious Diseases, 2004
- Clinical and Laboratory Characteristics of Infective Endocarditis When Associated with SpondylodiscitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Vertebral Osteomyelitis: Long‐Term Outcome for 253 Patients from 7 Cleveland‐Area HospitalsClinical Infectious Diseases, 2002
- Vertebral Osteomyelitis in Go¨teborg, Sweden: A Retrospective Study of Patients During 1990?95Scandinavian Journal of Infectious Diseases, 2001
- Spinal epidural abscess: contemporary trends in etiology, evaluation, and managementSurgical Neurology, 1999
- Coagulase-Negative Staphylococci: Pathogens Associated with Medical ProgressClinical Infectious Diseases, 1994
- Pyogenic Vertebral Osteomyelitis With ParalysisClinical Orthopaedics and Related Research, 1991
- Diagnosis and management of pyogenic vertebral osteomyelitis in adultsSurgical Neurology, 1990